Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.

Yeung TL, Leung CS, Yip KP, Sheng J, Vien L, Bover LC, Birrer MJ, Wong STC, Mok SC.

Clin Cancer Res. 2019 Nov 1;25(21):6417-6428. doi: 10.1158/1078-0432.CCR-19-0187. Epub 2019 Jul 22.

PMID:
31332047
2.

E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.

Bi E, Li R, Bover LC, Li H, Su P, Ma X, Huang C, Wang Q, Liu L, Yang M, Lin Z, Qian J, Fu W, Liu YJ, Yi Q.

J Clin Invest. 2018 Nov 1;128(11):4821-4831. doi: 10.1172/JCI121421. Epub 2018 Oct 2.

3.

Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo.

Qin H, Wei G, Sakamaki I, Dong Z, Cheng WA, Smith DL, Wen F, Sun H, Kim K, Cha S, Bover L, Neelapu SS, Kwak LW.

Clin Cancer Res. 2018 Mar 1;24(5):1114-1123. doi: 10.1158/1078-0432.CCR-17-1193. Epub 2017 Nov 27.

4.

Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.

Jiang H, Rivera-Molina Y, Gomez-Manzano C, Clise-Dwyer K, Bover L, Vence LM, Yuan Y, Lang FF, Toniatti C, Hossain MB, Fueyo J.

Cancer Res. 2017 Jul 15;77(14):3894-3907. doi: 10.1158/0008-5472.CAN-17-0468. Epub 2017 May 31.

5.

Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells.

Puebla-Osorio N, Damiani E, Bover L, Ullrich SE.

Cell Death Dis. 2015 May 7;6:e1745. doi: 10.1038/cddis.2015.115.

6.

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.

Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Cardó-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R.

Clin Cancer Res. 2015 Jul 1;21(13):3041-51. doi: 10.1158/1078-0432.CCR-13-3059. Epub 2015 Mar 16.

7.

New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice.

Arumugam T, Deng D, Bover L, Wang H, Logsdon CD, Ramachandran V.

Mol Cancer Ther. 2015 Apr;14(4):941-51. doi: 10.1158/1535-7163.MCT-14-0470. Epub 2015 Feb 2.

8.

Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.

Voo KS, Bover L, Harline ML, Weng J, Sugimoto N, Liu YJ.

J Immunol. 2014 Jul 15;193(2):627-34. doi: 10.4049/jimmunol.1203334. Epub 2014 Jun 13.

9.

Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS.

Int J Cancer. 2014 Dec 15;135(12):2834-46. doi: 10.1002/ijc.28937. Epub 2014 May 12.

10.

Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells.

Hu J, Vien LT, Xia X, Bover L, Li S.

Biol Proced Online. 2014 Feb 4;16(1):3. doi: 10.1186/1480-9222-16-3.

11.

Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.

Voo KS, Bover L, Harline ML, Vien LT, Facchinetti V, Arima K, Kwak LW, Liu YJ.

J Immunol. 2013 Oct 1;191(7):3641-50. doi: 10.4049/jimmunol.1202752. Epub 2013 Sep 6.

12.

CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl.

Bao M, Hanabuchi S, Facchinetti V, Du Q, Bover L, Plumas J, Chaperot L, Cao W, Qin J, Sun SC, Liu YJ.

J Immunol. 2012 Jul 15;189(2):786-92. doi: 10.4049/jimmunol.1200887. Epub 2012 Jun 15.

13.

Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.

Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, Zal T, Liu YJ.

Cell Res. 2012 Jul;22(7):1129-39. doi: 10.1038/cr.2012.45. Epub 2012 Mar 27.

14.

Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation.

Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AK.

J Exp Med. 2011 Mar 14;208(3):479-90. doi: 10.1084/jem.20102131. Epub 2011 Feb 21.

15.

Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells.

Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J, Liu YJ.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15181-6. doi: 10.1073/pnas.1006539107. Epub 2010 Aug 9.

16.

Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells.

Cao W, Bover L.

Immunol Rev. 2010 Mar;234(1):163-76. doi: 10.1111/j.0105-2896.2009.00867.x. Review.

17.

Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.

Cao W, Bover L, Cho M, Wen X, Hanabuchi S, Bao M, Rosen DB, Wang YH, Shaw JL, Du Q, Li C, Arai N, Yao Z, Lanier LL, Liu YJ.

J Exp Med. 2009 Jul 6;206(7):1603-14. doi: 10.1084/jem.20090547. Epub 2009 Jun 29.

18.

Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8. doi: 10.1073/pnas.0900408106. Epub 2009 Mar 9.

19.

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ.

Immunity. 2008 Jun;28(6):870-80. doi: 10.1016/j.immuni.2008.03.018. Epub 2008 May 29.

20.

BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells.

Cao W, Zhang L, Rosen DB, Bover L, Watanabe G, Bao M, Lanier LL, Liu YJ.

PLoS Biol. 2007 Sep 11;5(10):e248.

21.

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.

Bover LC, Cardó-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R.

J Immunol. 2007 Jun 15;178(12):8183-94.

22.

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.

Cao W, Rosen DB, Ito T, Bover L, Bao M, Watanabe G, Yao Z, Zhang L, Lanier LL, Liu YJ.

J Exp Med. 2006 Jun 12;203(6):1399-405. Epub 2006 May 30.

23.

Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.

Kolonin MG, Bover L, Sun J, Zurita AJ, Do KA, Lahdenranta J, Cardó-Vila M, Giordano RJ, Jaalouk DE, Ozawa MG, Moya CA, Souza GR, Staquicini FI, Kunyiasu A, Scudiero DA, Holbeck SL, Sausville EA, Arap W, Pasqualini R.

Cancer Res. 2006 Jan 1;66(1):34-40.

24.

CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells.

Mantegazza AR, Barrio MM, Moutel S, Bover L, Weck M, Brossart P, Teillaud JL, Mordoh J.

Blood. 2004 Aug 15;104(4):1183-90. Epub 2004 May 6.

PMID:
15130945
25.
26.

The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.

Bover L, Barrio M, Bravo AI, Slavutsky I, Larripa I, Bolondi A, Ayala M, Mordoh J.

Cell Mol Biol (Noisy-le-grand). 1998 May;44(3):493-504.

PMID:
9620446
27.

FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten.

Capurro M, Bover L, Portela P, Livingston P, Mordoh J.

Cancer Immunol Immunother. 1998 Feb;45(6):334-9.

PMID:
9490204
28.

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells.

Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL.

Nat Med. 1997 Feb;3(2):171-6.

PMID:
9018235
29.

The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL.

J Invest Dermatol. 1997 Feb;108(2):210-4.

30.

Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.

Mordoh J, Kairiyama C, Bover L, Solarolo E.

Medicina (B Aires). 1997;57(4):421-7.

PMID:
9674264
31.

Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.

Morvillo V, Bover L, Mordoh J.

Cell Mol Biol (Noisy-le-grand). 1996 Jul;42(5):779-95.

PMID:
8832109
32.

Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.

Ledda MF, Adris S, Bravo AI, Bover L, Carbone C, Paleolog E, Mordoh J, Chernajovsky Y, Podhajcer OL.

Cell Mol Biol (Noisy-le-grand). 1996 Jul;42(5):769-78.

PMID:
8832108
33.

[The role of SPARC gene in tumorigenic capacity of human melanoma cells].

Ledda MF, Adris S, Bover L, Bravo AL, Mordoh J, Podhajcer OL.

Medicina (B Aires). 1996;56(1):51-4. Spanish.

PMID:
8734932
34.

Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.

Kairiyama C, Slavutsky I, Larripa I, Morvillo V, Bravo AI, Bover L, Podhajcer OL, Mordoh J.

Pigment Cell Res. 1995 Jun;8(3):121-31.

PMID:
7567787
35.

Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi.

Podhajcer OL, Bover L, Bravo AI, Ledda MF, Kairiyama C, Calb I, Guerra L, Capony F, Mordoh J.

J Invest Dermatol. 1995 Mar;104(3):340-4.

36.

Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias.

Mordoh J, Leis S, Bravo AI, Podhajcer OL, Ballare C, Capurro M, Kairiyama C, Bover L.

Int J Biol Markers. 1994 Jul-Sep;9(3):125-34.

PMID:
7829891
37.

Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.

Bover L, Barrio M, Slavutsky I, Bravo AI, Quintans C, Bagnăti A, Lema B, Schiaffi J, Yomha R, Mordoh J.

Breast Cancer Res Treat. 1991 Sep;19(1):47-56.

PMID:
1661624
38.

Differentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J.

Guerra L, Bover L, Mordoh J.

Exp Cell Res. 1990 May;188(1):61-5.

PMID:
2328778
39.
40.
41.

In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.

Podhajcer OL, Bravo AI, Dain L, Guman N, Bover L, Mordoh J.

Cancer. 1988 May 1;61(9):1807-12.

PMID:
3281743
42.

Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer.

Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J.

Proc Natl Acad Sci U S A. 1987 Oct;84(20):7295-9.

43.

Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.

Cabral S, Leis S, Bover L, Nembrot M, Mordoh J.

Proc Natl Acad Sci U S A. 1984 May;81(10):3200-3.

Supplemental Content

Support Center